Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Astria Therapeutics(ATXS) the Revenue is 706 K (--%);the EBIT is -34.1 M (-17.54%);the EPS is -0.546 (-28.56%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.03B17.54%
----
----
EPS
-0.545528.56%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf